 Connection
Myron Levin to Antiviral Agents
This is a "connection" page, showing publications Myron Levin has written about Antiviral Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.374 |
|
|
|
-
Levin MJ, Ustianowski A, De Wit S, Launay O, Avila M, Templeton A, Yuan Y, Seegobin S, Ellery A, Levinson DJ, Ambery P, Arends RH, Beavon R, Dey K, Garbes P, Kelly EJ, Koh GCKW, Near KA, Padilla KW, Psachoulia K, Sharbaugh A, Streicher K, Pangalos MN, Esser MT. Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19. N Engl J Med. 2022 06 09; 386(23):2188-2200.
Score: 0.539
-
Levin MJ, Gershon AA, Dworkin RH, Brisson M, Stanberry L. Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol. 2010 May; 48 Suppl 1:S14-9.
Score: 0.235
-
Weinberg A, Leary JJ, Sarisky RT, Levin MJ. Factors that affect in vitro measurement of the susceptibility of herpes simplex virus to nucleoside analogues. J Clin Virol. 2007 Feb; 38(2):139-45.
Score: 0.186
-
Levin MJ, Bacon TH, Leary JJ. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. Clin Infect Dis. 2004 Nov 01; 39 Suppl 5:S248-57.
Score: 0.161
-
Levin MJ, Dahl KM, Weinberg A, Giller R, Patel A, Krause PR. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. J Infect Dis. 2003 Oct 01; 188(7):954-9.
Score: 0.149
-
Shin YK, Weinberg A, Spruance S, Bernard M, Bacon TH, Boon RJ, Levin MJ. Susceptibility of herpes simplex virus isolates to nucleoside analogues and the proportion of nucleoside-resistant variants after repeated topical application of penciclovir to recurrent herpes labialis. J Infect Dis. 2003 Apr 15; 187(8):1241-5.
Score: 0.144
-
Levin MJ, Weinberg A, Leary JJ, Sarisky RT. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum. Pediatr Infect Dis J. 2001 Nov; 20(11):1094-7.
Score: 0.130
-
Shin YK, Cai GY, Weinberg A, Leary JJ, Levin MJ. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates. J Clin Microbiol. 2001 Mar; 39(3):913-7.
Score: 0.124
-
Caruso Brown AE, Cohen MN, Tong S, Braverman RS, Rooney JF, Giller R, Levin MJ. Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients. Antimicrob Agents Chemother. 2015 Jul; 59(7):3718-25.
Score: 0.082
-
Hull CM, Levin MJ, Tyring SK, Spruance SL. Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis. Antimicrob Agents Chemother. 2014; 58(3):1273-8.
Score: 0.076
-
Weinberg A, Bate BJ, Masters HB, Schneider SA, Clark JC, Wren CG, Allaman JA, Levin MJ. In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2. Antimicrob Agents Chemother. 1992 Sep; 36(9):2037-8.
Score: 0.069
-
Rabalais GP, Nusinoff-Lehrman S, Arvin AM, Levin MJ. Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection. Pediatr Infect Dis J. 1989 Apr; 8(4):221-3.
Score: 0.054
-
Cunningham AL, Breuer J, Dwyer DE, Gronow DW, Helme RD, Litt JC, Levin MJ, Macintyre CR. The prevention and management of herpes zoster. Med J Aust. 2008 Feb 04; 188(3):171-6.
Score: 0.050
-
Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, Nurmikko TJ, Oaklander AL, Oxman MN, Pavan-Langston D, Petersen KL, Rowbotham MC, Schmader KE, Stacey BR, Tyring SK, van Wijck AJ, Wallace MS, Wassilew SW, Whitley RJ. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007 Jan 01; 44 Suppl 1:S1-26.
Score: 0.047
-
Muller WJ, Levin MJ, Shin YK, Robinson C, Quinones R, Malcolm J, Hild E, Gao D, Giller R. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin Infect Dis. 2005 Dec 15; 41(12):1812-6.
Score: 0.043
-
Bacon TH, Levin MJ, Leary JJ, Sarisky RT, Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev. 2003 Jan; 16(1):114-28.
Score: 0.035
-
Schnipper LE, Crumpacker CS, Marlowe SI, Kowalsky P, Hershey BJ, Levin MJ. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient. Am J Med. 1982 Jul 20; 73(1A):387-92.
Score: 0.034
-
Crumpacker CS, Schnipper LE, Marlowe SI, Kowalsky PN, Hershey BJ, Levin MJ. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med. 1982 Feb 11; 306(6):343-6.
Score: 0.033
-
Parker LM, Lipton JM, Binder N, Crawford EL, Kudisch M, Levin MJ. Effect of acyclovir and interferon on human hematopoietic progenitor cells. Antimicrob Agents Chemother. 1982 Jan; 21(1):146-50.
Score: 0.033
-
Levin MJ, Leary PL, Arbeit RD. Effect of acyclovir on the proliferation of human fibroblasts and peripheral blood mononuclear cells. Antimicrob Agents Chemother. 1980 Jun; 17(6):947-53.
Score: 0.030
-
Crumpacker CS, Schnipper LE, Zaia JA, Levin MJ. Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother. 1979 May; 15(5):642-5.
Score: 0.027
-
Mertz GJ, Loveless MO, Levin MJ, Kraus SJ, Fowler SL, Goade D, Tyring SK. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group. Arch Intern Med. 1997 Feb 10; 157(3):343-9.
Score: 0.023
-
Dworkin RH, Carrington D, Cunningham A, Kost RG, Levin MJ, McKendrick MW, Oxman MN, Rentier B, Schmader KE, Tappeiner G, Wassilew SW, Whitley RJ. Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res. 1997 Jan; 33(2):73-85.
Score: 0.023
-
Hull CM, Harmenberg J, Arlander E, Aoki F, Bring J, Darp? B, Levin MJ, Tyring S, Spruance SL. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial. J Am Acad Dermatol. 2011 Apr; 64(4):696.e1-11.
Score: 0.015
-
Rabalais GP, Levin MJ, Berkowitz FE. Rapid herpes simplex virus susceptibility testing using an enzyme-linked immunosorbent assay performed in situ on fixed virus-infected monolayers. Antimicrob Agents Chemother. 1987 Jun; 31(6):946-8.
Score: 0.012
-
Douglas JM, Judson FN, Levin MJ, Bosso JA, Spruance SL, Johnston JM, Corey L, McMillan JA, Weiner LB, Frank JA. A placebo-controlled trial of topical 8% arildone cream early in recurrent genital herpes. Antimicrob Agents Chemother. 1986 Mar; 29(3):464-7.
Score: 0.011
-
Meyers JD, Wade JC, Mitchell CD, Saral R, Lietman PS, Durack DT, Levin MJ, Segreti AC, Balfour HH. Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med. 1982 Jul 20; 73(1A):229-35.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|